Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19

PURPOSE: Real-world experience with tocilizumab in combination with dexamethasone in patients with severe coronavirus disease (COVID-19) needs to be investigated. MATERIALS AND METHODS: A retrospective cohort study was conducted to evaluate the effect of severity-adjusted dosing of dexamethasone in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jin Yeong, Ko, Jae-Hoon, Yang, Jinyoung, Ha, Soyoung, Nham, Eliel, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Chung, Doo Ryeon, Baek, Jin Yang, Sohn, You Min, Park, Hyo Jung, Lee, Beomki, Huh, Hee Jae, Kang, Eun-Suk, Suh, Gee Young, Chung, Chi Ryang, Peck, Kyong Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086692/
https://www.ncbi.nlm.nih.gov/pubmed/35512745
http://dx.doi.org/10.3349/ymj.2022.63.5.430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086692/
https://www.ncbi.nlm.nih.gov/pubmed/35512745
http://dx.doi.org/10.3349/ymj.2022.63.5.430

Ejemplares similares